Istradefylline forty mg/working day enhanced peak levels and AUC of CYP3A4 substrates in clinical trials. This effect was not observed with istradefylline 20 mg/working day. Consider dose reduction of sensitive CYP3A4 substrates.Prolonged use during pregnancy can lead to neonatal opioid withdrawal syndrome, which can be life-threatening Otherwise r